[Effect of seven kinds of flavonoids on recombinant human protein tyrosine phosphatase]

Tai-ping He1, Nian-ci Liang, Xiao-cong Lin

  • 1Institute of Biochemistry and Molecular Biology, Guangdong Medical College, Zhanjiang 524023, China. taipinghe@163.com

Abstract

Insights

Myricetin and gossypin strongly inhibit phosphatase of regenerating liver-3 (PRL-3) activity. This study identifies key flavonoid structures for developing novel PRL-3 inhibitors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Context:

  • Phosphatase of regenerating liver-3 (PRL-3) is a protein tyrosine phosphatase implicated in cancer metastasis.
  • Targeting PRL-3 activity presents a potential therapeutic strategy for inhibiting cancer progression.

Purpose:

  • To investigate the inhibitory effects of seven distinct flavonoids on recombinant human PRL-3 activity.
  • To determine the structure-activity relationships of flavonoids influencing PRL-3 inhibition.

Summary:

  • Myricetin and gossypin demonstrated significant, dose-dependent inhibition of PRL-3, with IC50 values of 55.54 and 68.86 µmol/L, respectively.
  • Quercetin, luteolin, and 7,8-dihydroxyflavone exhibited weaker inhibition, while 3-hydroxyflavone and 6-hydroxyflavone showed no significant effect.
  • The presence of hydroxyl groups at the C4 and C7 positions of the flavone skeleton was crucial for PRL-3 inhibitory activity, with increased hydroxyl numbers correlating with enhanced inhibition.

Impact:

  • Identifies myricetin and gossypin as potent inhibitors of human PRL-3.
  • Provides insights into the structural requirements for flavonoid-based PRL-3 inhibitors.
  • Suggests potential for developing novel anti-cancer therapeutics targeting PRL-3.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...